Home
About
FAQ
History (10)
Gaddy, Jeremiah
Improved Scalability of Neuron-Based Phenotypic Screening Assays for Therapeutic Discovery in Neuropsychiatric Disorders.
Chronic kidney disease and intensive glycemic control increase cardiovascular risk in patients with type 2 diabetes.
Helping Older Adults Improve Their Medication Experience (HOME) by Addressing Medication Regimen Complexity in Home Healthcare.
Moore, Laura
See All 10 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Search Results (79)
More Search Options
Sort
Query Relevance
Name (A-Z)
Name (Z-A)
Institution (A-Z)
Institution (Z-A)
Show
(choose columns)
Faculty Rank
Name
Institution
Why
Anthony Atala MD
Wake Forest School of Medicine
Why?
Joel D. Stitzel Jr. PhD
Wake Forest School of Medicine
Why?
Osvaldo Delbono MD, PhD
Wake Forest School of Medicine
Why?
Joseph Yeboah MD, MS,FACC,FAHA
Wake Forest School of Medicine
Why?
Kristen F. Nicholson PhD
Wake Forest School of Medicine
Why?
Fei Xing PhD
Wake Forest School of Medicine
Why?
Jared A. Weis PhD
Wake Forest School of Medicine
Why?
Suzanne C. Danhauer PhD
Wake Forest School of Medicine
Why?
David X. Zhao MD
Wake Forest School of Medicine
Why?
Leon Lenchik MD
Wake Forest School of Medicine
Why?
Ashley A. Weaver PhD
Wake Forest School of Medicine
Why?
David M. Reboussin PhD
Wake Forest School of Medicine
Why?
John S. Shields MD
Wake Forest School of Medicine
Why?
William P. Bozeman MD
Wake Forest School of Medicine
Why?
Barbara Nicklas PhD
Wake Forest School of Medicine
Why?
Per Page
15
25
50
100
Page
of 6
Next
Prev
Search Criteria
Gravitation
Click "Why?" to see why a person matched the search.
Search Options
Modify Search
Search Other Institutions